Two Sigma Securities’s eFFECTOR Therapeutics, Inc. Common Stock EFTR Stock Holding History

Two Sigma Securities’s Portfolio EFTR Stock Details EFTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-2,468	Closed	-$28.8K	–	3819
2023 Q4	$28.8K	Buy	+2,468	New	+$33.1K	﹤0.01%	2671
2023 Q2	–	Sell	-985	Closed	-$8.69K	–	3484
2023 Q1	$8.69K	Buy	+985	New	+$11.9K	﹤0.01%	2476
2022 Q4	–	Sell	-648	Closed	-$9K	–	3400
2022 Q3	$9K	Buy	+648	New	+$12.7K	﹤0.01%	2422

Other funds holding EFTR

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return

Stempoint Capital New York $522M AUM 281.95% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Two Sigma Securities's EFTR Position: Q1 2024 in Review

Two Sigma Securities sold out of eFFECTOR Therapeutics, Inc. Common Stock (EFTR) in Q1 2024, closing a stake of 2,468 shares — an estimated $28.8K sold.

Two Sigma Securities first reported a position in EFTR in Q3 2022 and held it in 3 quarters. The position peaked at $28.8K in Q4 2023. 17 funds tracked by Wall St. Rank hold EFTR as of Q1 2024.

Two Sigma Securities reported no remaining eFFECTOR Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Two Sigma Securities sold 2,468 eFFECTOR Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $28.8K.
Two Sigma Securities first reported a position in eFFECTOR Therapeutics, Inc. Common Stock in Q3 2022 and held it in 3 quarters.
Two Sigma Securities's eFFECTOR Therapeutics, Inc. Common Stock position peaked at $28.8K in Q4 2023.
17 funds tracked by Wall St. Rank held eFFECTOR Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Two Sigma Securities's 13F filing for Q1 2024, filed 15 May 2024.